Late-Breaking Data from PROTECTED TAVR Trial Demonstrate Reduced Risk of Disabling Stroke, Low Complication Rate with SENTINEL[TM] Cerebral Protection System

Source :: Medical Devices & Surgical Technology Week. October 9, 2022, 306
Publication Year :: 2022
Abstract: 2022 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Boston Scientific Corporation (NYSE:BSX) has announced results from the PROTECTED TAVR [...]

Subjects :: Boston Scientific Corp. -- Product development
Medical equipment -- Product development
Stroke (Disease) -- Risk factors
Data security
Medical test kit industry -- Product development
Medical equipment and supplies industry -- Product development
Physiological apparatus -- Product development
Data security issue
Health
Health care industry

Tools